Key Market Indicators
Estonian analgesic medicine sales are set to reach $13 million by 2026, growing at a 2.5% annual rate. In 2021, the market was worth $11.2 million, coming in at number 24 in the global rankings. This marks a 9% increase from 2004. New Zealand overtook Estonia in 2021, with sales of $11.2 million. Spain, Canada and Italy took the top three spots respectively.
